tiprankstipranks
Trending News
More News >
SpectraCure AB (DE:2OK)
:2OK
Germany Market

SpectraCure AB (2OK) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
SpectraCure AB’s (2OK) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting SpectraCure AB is a Sell.
SpectraCure AB’s (2OK) 20-Day exponential moving average is 0.03, while SpectraCure AB’s (2OK) share price is <€0.1, making it a Sell.
SpectraCure AB’s (2OK) 50-Day exponential moving average is 0.04, while SpectraCure AB’s (2OK) share price is <€0.1, making it a Sell.

SpectraCure AB (2OK) Pivot Points

Jun 13, 2025, 12:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SpectraCure AB (2OK) Moving Averages

Jun 13, 2025, 12:42 AM
Period
Simple
Exponential
MA5
0.03Sell
0.03Sell
MA10
0.03Sell
0.03Sell
MA20
0.03Sell
0.03Sell
MA50
0.04Sell
0.04Sell
MA100
0.06Sell
0.05Sell
MA200
0.06Sell
0.06Sell
SpectraCure AB’s (2OK) 10-Day exponential moving average is 0.03, while SpectraCure AB’s (2OK) share price is <€0.1, making it a Sell.
SpectraCure AB’s (2OK) 100-Day exponential moving average is 0.05, while SpectraCure AB’s (2OK) share price is <€0.1, making it a Sell.
SpectraCure AB’s (2OK) stock price is <€0.1 and SpectraCure AB’s (2OK) 50-day simple moving average is 0.04, creating a Sell signal.
SpectraCure AB’s (2OK) stock price is <€0.1 and SpectraCure AB’s (2OK) 100-day simple moving average is 0.06, creating a Sell signal.
SpectraCure AB’s (2OK) stock price is <€0.1 and SpectraCure AB’s (2OK) 200-day simple moving average is 0.06, creating a Sell signal.

SpectraCure AB (2OK) Technical Indicators

Jun 13, 2025, 12:42 AM
Name
Value
Implied Action
RSI (14)
43.91
Neutral
STOCH (9,6)
12.70
Buy
STOCHRSI (14)
12.95
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
25.13
Neutral
Williams %R
-89.61
Buy
CCI (14)
-51.77
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
47.20
Neutral
ROC
0.00
Buy
SpectraCure AB’s (2OK) Relative Strength Index (RSI) is 43.91, creating a Neutral signal.
SpectraCure AB’s (2OK) Trend Strength Indicator (ADX) is 25.13, creating a Neutral signal.
SpectraCure AB’s (2OK) Commodity Channel Index (CCI) is -51.77, creating a Neutral signal.

FAQ

Is 2OK a Buy, Hold, or Sell?
Based on 2OK’s technical indicators, 2OK is a Strong Sell.
    What is 2OK’s RSI (14)?
    2OK’s RSI (14) is 43.91, which suggests 2OK is a Neutral.
      What is 2OK’s MACD?
      2OK’s MACD is >-0.01, which suggests 2OK is a Sell.
        What is 2OK’s 5-day moving average?
        2OK’s 5-day moving average is 0.03, which suggests 2OK is a Sell.
          What is 2OK’s 20-day moving average?
          2OK 20-day moving average is 0.03, which suggests 2OK is a Sell.
            What is 2OK’s 50-day moving average?
            2OK’s 50-day moving average is 0.04, which suggests 2OK is a Sell.
              What is 2OK’s 200-day moving average?
              2OK’s 200-day moving average is 0.06, which suggests 2OK is a Sell.
                What is 2OK’s Williams % R (14)?
                2OK’s Williams % R (14) is -89.61, which suggests 2OK is a Buy.
                  What is 2OK’s CCI (14)?
                  2OK’s CCI (14) is -51.77, which suggests 2OK is a Neutral.
                    What is the share price of SpectraCure AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis